We have previously defined major histocompatibility complex (MHC) class II-restricted T-cell epitopes from the carboxy-terminal region of group A streptococcal type 5 M protein. In this report, T-cell responses to one of these epitopes have been characterized in detail. T-cell clones from recombinant M5-immunized mice and popliteal lymph node cells from peptide-immunized mice were used to show that sM5[300-3191 is recognized in the context of I-A alleles of four of nine independent MHC class II haplotypes: I-Ad, I-Af, I-Ak, and I-AS. This epitope was also recognized by both helper (Th2) and inflammatory (Thl) subsets of murine T cells. The I-Ad-restricted epitope recognized by BALB/c mice was mapped to the 12-amino-acid peptide sM5 [308-3191 and was M proteins are one of the major virulence factors expressed by Streptococcus pyogenes, as well as being the principal protective antigens recognized by the host (9, 15, 29). They form fibrillar a-helical coiled-coil dimers protruding from the surface of group A streptococci which mediate resistance to phagocytosis through their ability to bind mammalian proteins, including fibrinogen (26) and complement factor H (14), preventing effective opsonization by the alternative complement pathway. Sequence variability in the protruding amino-terminal halves of the molecules defines multiple M types, but the carboxy-terminal halves, which are located closer to the cell surface, are highly conserved between M types. Many M types elicit antibodies which cross-react with human fibrillar proteins such as cardiac myosin (7) and glomerular vimentin (18), and it has been suggested that these autoantibodies contribute to the pathogenesis of rheumatic fever (5) and poststreptococcal glomerulonephritis (30).
M proteins are one of the major virulence factors expressed by Streptococcus pyogenes, as well as being the principal protective antigens recognized by the host (9, 15, 29) . They form fibrillar a-helical coiled-coil dimers protruding from the surface of group A streptococci which mediate resistance to phagocytosis through their ability to bind mammalian proteins, including fibrinogen (26) and complement factor H (14) , preventing effective opsonization by the alternative complement pathway. Sequence variability in the protruding amino-terminal halves of the molecules defines multiple M types, but the carboxy-terminal halves, which are located closer to the cell surface, are highly conserved between M types. Many M types elicit antibodies which cross-react with human fibrillar proteins such as cardiac myosin (7) and glomerular vimentin (18) , and it has been suggested that these autoantibodies contribute to the pathogenesis of rheumatic fever (5) and poststreptococcal glomerulonephritis (30) .
Effective protection against streptococcal infection is mediated by opsonic antibodies directed against antibody epitopes located in the amino-terminal half of M protein molecules, and attempts to develop M protein vaccines have been complicated because effective protection is predominantly M type specific (2) . In addition, the existence of both protective and host cross-reactive epitopes within the same covalent structure requires that M protein vaccines are based on well-characterized, defined epitopes. Extensive efforts have been made in the past 10 years to identify and characterize M protein antibody epitopes to facilitate the design of M protein-based streptococcal vaccines (16) . However, until recently the study of antigen-specific T-cell responses to M proteins was limited (3, 8) . We have identified * Corresponding author. multiple epitopes recognized by T cells of mice immunized with purified, recombinant type 5 M protein (rM5). The responses of rM5-specific, major histocompatibility complex (MHC) class II-restricted T-cell clones to synthetic peptides representing most of the M5 sequence identified at least 13 distinct T-cell recognition sites, distributed throughout both variable amino-terminal and conserved carboxy-terminal regions of M5 (28) . Helper-T-cell epitopes located in the carboxy-terminal region of M5 which were conserved between M types could be particularly useful in the design of multivalent, defined-epitope M vaccines. The aim of the present study was to characterize in detail responses to a major carboxy-terminal MHC class II-restricted T-cell epitope from M5.
MATERIALS AND METHODS
Synthetic peptides and rM5. The synthetic peptides representing the M5 sequence 300 to 319 and 15 to 33 were synthesized on an Applied Biosystems (Warrington, United Kingdom) automated peptide synthesizer (model 431A) by using f-moc chemistry and a Beckman 990 peptide synthesizer by using solid-phase t-boc chemistry, respectively. The composition and purity of the peptides were confirmed by amino acid analysis and high-performance liquid chromatography, respectively. Purified peptides were dialyzed against phosphate-buffered saline, filter sterilized, and stored in aliquots at -80°C. rM5-specific T-cell clones. Seven days after footpad immunization, rM5-specific T cells were cloned directly by limiting dilution from popliteal lymph node cells (PLN) as described previously (28 H2SO4, and A492 was measured by using a microtiter plate reader (MR5000; Dynatech Ltd., Billingshurst, Sussex, United Kingdom).
RESULTS
MHC restriction phenotype and fine specificity of rM5-specific T-cell clones. We have previously shown that a significant proportion of rM5-specific T-cell clones from BALB/c and CBA.Ca mice immunized with rM5 in FCA recognized the synthetic peptide M5[300-319] in vitro (28) . The MHC restriction phenotype of BALB/c and CBA M5[300-319]-specific T-cell clones was determined by using spleen cells from intra H-2 recombinant mice as antigenpresenting cells (Fig. 1) and were presumed to be of the Th1 phenotype, whereas clone X12 produced IL-4 but little or no IL-2 and was considered to be of the Th2 type (Fig. 2) . From this limited amount of data it can be concluded that M5[300-319] is recognized by both Th1 and Th2 subsets of helper-T cells.
The fine specificity of BALB/c M5[300-319]-specific clones was mapped by using a limited range of peptides of 12 amino acids in length (Fig. 3) [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] , and PLN cells were assayed for proliferation in vitro (Fig. 4) (Fig. 6) . Antibody binding to sM5[300-319] (Fig. 6a) , sM5 [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] (Fig. 6b) , or rM5 (Fig. 6c) [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] , which also reacted with rM5. These results show that each peptide, unlinked to a carrier, induced a specific antibody response, indicating that the T-cell recognition site on the peptide could function as a helper-T-cell epitope for an antibody response directed against an antibody epitope within the same peptide. In addition, sera from rM5-immunized mice contained rM5-specific antibodies that did not react with sM5 [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] 
DISCUSSION
The expression and purification of rM5 (22) and rM6 (13) proteins of group A streptococci have led to the identification of immune recognition sites throughout the entire length of these molecules. In M5 and M6, antibody epitopes have been mapped to several regions, in both variable and conserved halves of the molecules (2, 10, 29) . However protective, opsonic antibodies are M type specific and are directed predominantly towards the amino-terminal half of M proteins (10, 29) . In contrast, multiple T-cell epitopes have been located in both variable amino-terminal and conserved carboxy-terminal halves of M5 (28) , and it can be predicted that epitopes in the carboxy-terminal regions of M proteins will be shared between different M types. However, the conserved carboxy-terminal region of M proteins is located below the cell wall on intact streptococci (25) , and it is not known whether T-cell epitopes from this region can be processed and presented to helper T cells and whether these T cells could then augment protective antibody responses directed against the amino-terminal half of the M protein.
We have previously localized T-cell recognition in BALB/c mice to at least two distinct synthetic peptides from the carboxy-terminal half of M5, in addition to six synthetic peptides from the amino-terminal half (28) . One of the carboxy-terminal peptides, sM5[300-319], was also recognized by T cells of CBA mice. The aim of the present study was to characterize the T-cell epitope(s) within M5[300-319]. The MHC restriction phenotype of peptide-specific T-cell clones was investigated. Antigen presentation by spleen cells from intra H-2 recombinant mice demonstrated that BALB/c and CBA.Ca T-cell clones were Ad and Ak restricted, respectively. The MHC restriction phenotype was also confirmed by the ability of monoclonal anti-MHC class II antibodies to block proliferation of T-cell clones. However, complete blocking by antibodies was not achieved, suggesting that the affinity of peptide 300 to 319 for Ad and Ak molecules and/or the T-cell receptor was relatively high. Also, PLN proliferation responses elicited from sM5[300-319]-immunized B1O.M and B1U.S mice were likely to be Af and As restricted, respectively, as these strains fail to express cell surface I-E molecules (21) . Thus, sM5[300-319] binds to at least four distinct alleles of I-A. The poor immunogenicity of sM5[300-319] in CBA.Ca mice was unexpected considering the frequency of M5[300-319]-specific T-cell clones derived from CBA.Ca mice (28) . The observation that PLN from peptide-immunized C3H.NB mice proliferated in response to rM5, but not to sM5[300-319], suggested that the free peptide was further degraded in vitro by antigen-presenting cells of this strain of mice, since the response to processed rM5 indicated that the immunization against M5[300-319] was successful.
The fine recognition specificity of a limited number of BALB/c M5[300-319]-specific T-cell clones was localized to the 12-amino-acid peptide 308 to 319. This sequence appears once only in M5, despite the large proportion of the molecule represented as regions of repeated sequence (9) . This epitope was located adjacent to the C repeats of M5, and a region of identical sequence is observed in M6, M12, M24, and M57, after partial sequence alignment. A closely similar sequence was also found in M49, which has been shown to belong to a structurally distinct class of M protein (4 (22) , M6 (13) , M12 (27) , M24 (24) , M49 (12) , and M57 (20) It has been reported that M proteins have the properties of superantigens (31, 32) , with important consequences for the understanding of streptococcal virulence. However, type 5 M proteins cleaved from the surface of streptococci with pepsin (pepM5 fragments) were used in these studies, and it has subsequently been shown that the superantigenicity of pepMl and pepM5 preparations is due to contamination with streptococcal pyrogenic exotoxins (11) .
In conclusion, M5[300-319] includes a helper-T-cell epitope conserved between several M types which was shown to be presented by I-A molecules to different subsets of helper-T cells from multiple MHC haplotypes. Therefore, a helper-T-cell epitope which has potential use in the design of multivalent M protein-based streptococcal vaccines has been defined. We are currently developing such vaccines for evaluation in animal infection models.
